血液公司
US ˙ NYSE ˙ US4050241003

SecurityHAE / Haemonetics Corporation
InstitutionAdvisor Group, Inc.
Latest Disclosed Ownership4,559 shares
Latest Disclosed Value $ 524,000
Advisor Group, Inc. reports 3.94% increase in ownership of HAE / Haemonetics Corporation

On February 12, 2020 - Advisor Group, Inc. filed a 13F-HR form disclosing ownership of 4,559 shares of Haemonetics Corporation (US:HAE) valued at $523,829 USD as of December 31, 2019. The entity filed a previous 13F-HR on November 13, 2019 disclosing 4,386 shares of Haemonetics Corporation. This represents a change in shares of 3.94% during the quarter. The current value of the position is $324,966 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2020-02-12 2019-12-31 13F HAEMONETICS COM 405024100 4,559 173 3.94 524 -5.24 0.0036
2019-11-13 2019-09-30 13F HAEMONETICS COM 405024100 4,386 1,794 69.21 553 76.68 0.0041
2019-07-31 2019-06-30 13F HAEMONETICS COM 405024100 2,592 -2,822 -52.12 313 -33.83 0.0024
2019-05-09 2019-03-31 13F HAEMONETICS COM 405024100 5,414 3,392 167.75 473 133.00 0.0039
2019-02-11 2018-12-31 13F HAEMONETICS COM 405024100 2,022 1,739 614.49 203 534.38 0.0020
2018-11-14 2018-09-30 13F HAEMONETICS COM 405024100 283 6 2.17 32 28.00 0.0003
2018-08-13 2018-06-30 13F HAEMONETICS COM 405024100 277 -838 -75.16 25 -69.14 0.0003
2018-05-15 2018-03-31 13F HAEMONETICS COM 405024100 1,115 -19 -1.68 81 22.73 0.0011
2018-02-14 2017-12-31 13F HAEMONETICS COM 405024100 1,134 -9 -0.79 66 29.41 0.0009
2017-11-06 2017-09-30 13F HAEMONETICS COM 405024100 1,143 -74 -6.08 51 6.25 0.0008
2017-11-03 2017-06-30 13F/A-1 HAEMONETICS COM 405024100 1,217 49 4.20 48 2.13 0.0008
2017-08-11 2017-06-30 13F HAEMONETICS COM 405024100 1,217 49 47
2017-11-02 2017-03-31 13F/A-1 HAEMONETICS COM 405024100 1,168 14 1.21 47 2.17 0.0009
2017-05-15 2017-03-31 13F HAEMONETICS COM 405024100 1,168 14 47
2017-11-02 2016-12-31 13F/A-1 HAEMONETICS COM 405024100 1,154 -418 -26.59 46 -19.30 0.0010
2017-01-31 2016-12-31 13F HAEMONETICS COM 405024100 1,154 -418 46
2017-11-02 2016-09-30 13F/A-1 HAEMONETICS COM 405024100 1,572 -118 -6.98 57 18.75 0.0014
2016-11-08 2016-09-30 13F HAEMONETICS COM 405024100 1,572 -118 57
2016-08-11 2016-06-30 13F HAEMONETICS COM 405024100 1,690 48
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.